Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px
Document › Details

Oxford Medical Diagnostics Ltd.. (3/7/11). "Press Release: Oxford Medical Diagnostics and V&F Join Forces".

Region Region United Kingdom (GB)
Organisations Organisation Oxford Medical Diagnostics Ltd.
  Group Avacta (Group)
  Organisation 2 V&F Analyse- und Messtechnik GmbH
  Group V&F (Group)
Products Product IMR-MS system (Ion Molecule Reaction Mass Spectrometry system)
  Product 2 gas analyser
Index term Index term Avacta–V&F: mass spectrometer, 201103 distribution of IMR-MS systems + services in UK + IRL by Oxford Molecular Diagnostics
Persons Person Marchington, Tony (Avacta 201103 CEO of Oxford Medical Diagnostics)
  Person 2 Federer, Werner (V&F 201103 President)

Oxford Medical Diagnostics (OMD), the UK developer of breath based, medical diagnostic technology for the rapid, non-invasive, accurate and low-cost diagnosis and monitoring of metabolic and infectious diseases; and V&F Analyse- und Messtechnik GmbH (V&F), a provider of analytical instruments to a wide range of industries, today announced a strategic alliance focusing on the area of mass spectrometry.

Under the terms of the new agreement with V&F, Oxford Medical Diagnostics will offer and support V&F's high-performance mass spectrometry analyzers in the UK and Ireland. Also, OMD will establish a contract batch sample analysis service in its Oxford laboratories to provide analytical services to third party customers using V&F's mass spectrometers.

OMD will bring to bear its expertise in spectrometry and is itself developing the Acetone Breath Analyzer, based on its proprietary infrared absorption spectroscopy. The device will be used to screen and diagnose Type 1 and Type 2 diabetes, as well as monitor weight-loss in healthy individuals.

Target markets for mass spectrometry and allied contract analytical services are substantial. They include pharmaceuticals, biotechnology, aerospace, fine chemicals, oil & gas, the environment and food & beverages. OMD already uses V&F's leading mass spectrometry technology as the gold standard with which to compare clinical results from diabetic patients with OMD's proprietary laser based breath analysis solutions. The joint offering now implies a much closer working relationship between the two companies.

In addition to this collaboration, the two companies are looking into other opportunities for joint research. These include bacterial headspace analysis - analyzing the space above bacteriological samples such as MRSA and Clostridium difficile - as well as sports performance monitoring and healthy weight loss management.

"This is a great alliance for OMD, linking us to one of the most talented molecular analysis companies in the world. It brings analytical know-how, and the opportunity to earn revenues - an important discipline for early-stage companies, like ours," said Oxford Medical Diagnostics CEO, Tony Marchington.

"We project an exciting future working with OMD," said Dr Werner Federer, President of V&F. "Diabetes and lifestyle-weight loss represent significant opportunities for both our companies."

About V&F

V&F Analyse- und Messtechnik GmbH of Absam, Austria has been designing and manufacturing Mass Spectrometers (MS) for real-time gas analysis based on industrial and laboratory proven technology, Ion Molecule Reaction Mass Spectrometry ('IMR-MS'), for over 25 years. IMR-MS, also known as 'soft ionization', coupled with a patented ion transfer technique provides a combination of high-speed analysis, ultra high-sensitivity and range, and industrial level ruggedness unsurpassed in the gas analysis field. Today, several hundred of V&F gas analyzers provide critical gas component analysis for automotive and diesel research, food and beverage quality control, environmental and medical applications. In the US, V&F distribute through wholly owned subsidiaries, V&F Instruments and V&F Gas Analysis Systems.

For more information:

Record changed: 2016-01-10


Picture [LSUS] – The Business Web Portal 650x65px

More documents for Avacta (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top